Cargando…
Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice
Rationale: The blood-brain barrier (BBB) prevents the effective delivery of therapeutic molecules to the central nervous system (CNS). A recently generated adeno-associated virus (AAV)-based vector, AAV-PHP.eB, has been found to penetrate the BBB more efficiently than other vectors including AAV-PHP...
Autores principales: | Xie, Bao-Shu, Wang, Xin, Pan, Yao-Hua, Jiang, Gan, Feng, Jun-Feng, Lin, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738887/ https://www.ncbi.nlm.nih.gov/pubmed/33391529 http://dx.doi.org/10.7150/thno.46992 |
Ejemplares similares
-
Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
por: Jang, Seongmin, et al.
Publicado: (2022) -
AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice
por: Palfi, Arpad, et al.
Publicado: (2022) -
CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
por: Mathiesen, Sophie N., et al.
Publicado: (2020) -
Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
por: Arotcarena, Marie-Laure, et al.
Publicado: (2021) -
Widespread labeling and genomic editing of the fetal central nervous system by in utero CRISPR AAV9-PHP.eB administration
por: Hu, Shuntong, et al.
Publicado: (2021)